EUVIMEDEUVIMED entdecken
Crossref

WO 3‐x @Ferrocene‐Folic Acid Composites Induce Cancer Cell Death and Activate Immunity via PTT/CDT

Qi Wu, Mingyang Liu, Hui Zhang, Guanghao Li, Ziqing Yang, Xiaodan Wu, Guanghui Tan, Chenfeng Ji, Yingxue Jin iD

Small · 2025

DOI: 10.1002/smll.202500104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Qi Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry and Chemical Engineering, Harbin Normal Uni…. Hauptthemen laut MEDLINE: Ferrous Compounds, Tungsten, Metallocenes, Oxides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Key Projects of Natural Science Foundation of Heilongjiang Province (China), Heilongjiang Province Natural Science Foundation Project (China), Postgraduate Innovation Project Fund of Harbin Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

At present, tumor immune escape is a major problem in the treatment of tumors. The complex network of tumor microenvironments significantly impairs the efficacy of immunotherapy. This paper reports the preparation and immunoantitumor activity of a novel multifunctional defect tungsten trioxide@ferrocene‐folic acid composite (WO 3‐x @Fe‐FA) with a high Fenton reaction rate. Ferrocene is modified on the surface of defective trioxide by the covalent coupling method for the first time, and the reaction rate of Fenton is increased by 10 times. WO 3‐x @Fe‐FA induces immunogenic cell death (ICD) through the powerful synergistic anti‐tumor effect of PTT/CDT and decomposes H 2 O 2 to produce oxygen through the Fenton reaction, thus down‐regulating the expression of immune checkpoint PD‐L1 induced by tumor hypoxia. In vitro and in vivo experiments proved that WO 3‐x @Fe‐FA reverses the immunosuppressive tumor microenvironment, transforms the immunosuppressive “cold tumor” into the immune “hot tumor”, and activates the immune activity of the system. In vitro and in vivo experiments show that WO 3‐x @Fe‐FA has excellent immunoantitumor activity, and it is expected to be a candidate drug for immunoantitumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ferrous CompoundsTungstenMetallocenesOxidesFolic AcidAnimalsCell Line, TumorHumansMiceCell DeathTumor Microenvironment

Stichwörter der Autor:innen

defect tungsten oxidesferroceneimmunogenic cell death (ICD)self‐oxygenationtumor microenvironment

Substanzen

Ferrous CompoundsTungstenMetallocenesferroceneOxidestungsten oxideFolic Acid

Autor:innen und Institutionen

  • Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry and Chemical Engineering, Harbin Normal University, Harbin, 150025, China.
  • College of Public Health, Mudanjiang Medical University, Mudanjiang, 157009, China.
  • School of Basic Medical Sciences, Shandong University, Jinan, 250012, China.
  • College of Pharmacy, Harbin University of Commerce, Harbin, 150076, China.

ORCID-Profile: Yingxue Jin

Förderung

  • Key Projects of Natural Science Foundation of Heilongjiang Province (China)
  • Heilongjiang Province Natural Science Foundation Project (China)
  • Postgraduate Innovation Project Fund of Harbin Normal University

Zitieren

APA

Wu, Q., Liu, M., Zhang, H., Li, G., Yang, Z., Wu, X., Tan, G., Ji, C., & Jin, Y. (2025). WO 3‐x @Ferrocene‐Folic Acid Composites Induce Cancer Cell Death and Activate Immunity via PTT/CDT. Small. https://doi.org/10.1002/smll.202500104

Vancouver

Wu Q, Liu M, Zhang H, Li G, Yang Z, Wu X, et al. WO 3‐x @Ferrocene‐Folic Acid Composites Induce Cancer Cell Death and Activate Immunity via PTT/CDT. Small. 2025. doi:10.1002/smll.202500104

BibTeX
@article{Wu2025,
  author = {Wu, Qi and Liu, Mingyang and Zhang, Hui and Li, Guanghao and Yang, Ziqing and Wu, Xiaodan and Tan, Guanghui and Ji, Chenfeng and Jin, Yingxue},
  title = {WO 3‐x @Ferrocene‐Folic Acid Composites Induce Cancer Cell Death and Activate Immunity via PTT/CDT},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202500104}
}
Kostenlos starten →